SEC CIK 1202433
LYONS IRVING F III
Reported ownership across 3 companies, sourced from SEC Form 4 filings and updated daily.
Current Positions
| Company | Shares Owned | As Of |
|---|---|---|
| PLDview stock → | 43,825 | 2026-04-28 |
| ESSview stock → | 9,809 | 2026-05-12 |
| EQIXview stock → | 0 | 2021-08-30 |
Position History — ESS
Reported shares owned immediately after each Form 4 transaction, over time.
Recent Filings — ESS
| Date | Activity | Shares | Price | Owned After |
|---|---|---|---|---|
| 2026-05-12 | Grant / award | 633 | $0.00 | 9,809 |
| 2025-05-22 | J | 585 | $0.00 | 585 |
| 2025-05-22 | J | 585 | $0.00 | 9,176 |
| 2025-05-13 | Grant / award | 606 | $0.00 | 9,761 |
| 2024-05-14 | Grant / award | 585 | $0.00 | 9,155 |
| 2024-02-28 | Option exercise (derivative) | 2,781 | $0.00 | 0 |
| 2024-02-28 | Open-market sale | 2,083 | $230.90 | 8,570 |
| 2024-02-28 | Option exercise | 2,781 | $172.89 | 10,653 |
| 2023-05-09 | Grant / award (derivative) | 7,298 | $0.00 | 7,298 |
| 2022-05-10 | Grant / award (derivative) | 6,130 | $0.00 | 6,130 |
| 2021-11-24 | Option exercise (derivative) | 2,412 | $0.00 | 0 |
| 2021-11-24 | Option exercise | 2,412 | $254.33 | 10,284 |
| 2021-11-24 | Open-market sale | 2,412 | $354.33 | 7,872 |
| 2021-07-20 | Option exercise (derivative) | 7,329 | $0.00 | 0 |
| 2021-07-20 | Open-market sale | 7,329 | $329.90 | 7,872 |
| 2021-07-20 | Option exercise | 7,329 | $229.90 | 15,201 |
| 2021-07-14 | Option exercise (derivative) | 2,609 | $0.00 | 0 |
| 2021-07-14 | Open-market sale | 2,609 | $324.28 | 7,872 |
| 2021-07-14 | Option exercise | 2,609 | $224.28 | 10,481 |
| 2021-05-11 | Grant / award (derivative) | 4,948 | $0.00 | 4,948 |
| 2020-05-12 | Grant / award (derivative) | 7,329 | $0.00 | 7,329 |
| 2020-02-20 | Option exercise (derivative) | 2,500 | $0.00 | 0 |
| 2020-02-20 | Option exercise | 2,500 | $224.05 | 10,372 |
| 2020-02-20 | Open-market sale | 2,500 | $324.05 | 7,872 |
| 2020-01-31 | Option exercise (derivative) | 2,838 | $0.00 | 0 |
| 2020-01-31 | Open-market sale | 2,838 | $309.92 | 7,872 |
| 2020-01-31 | Option exercise | 2,838 | $179.48 | 10,710 |
| 2019-05-14 | Grant / award (derivative) | 4,180 | $0.00 | 4,180 |
| 2018-05-15 | Grant / award (derivative) | 2,083 | $0.00 | 2,083 |
| 2017-05-18 | Option exercise (derivative) | 1,528 | $0.00 | 0 |
| 2017-05-18 | Option exercise | 1,528 | $170.30 | 8,854 |
| 2017-05-18 | Open-market sale | 1,024 | $254.22 | 7,830 |
| 2017-05-16 | Grant / award (derivative) | 2,412 | $0.00 | 2,412 |
| 2016-05-17 | Grant / award (derivative) | 2,609 | $0.00 | 2,609 |
| 2016-05-05 | Option exercise (derivative) | 2,678 | — | 0 |
| 2016-05-05 | Option exercise | 2,678 | $140.46 | 8,973 |
| 2016-05-05 | Open-market sale | 2,678 | $228.67 | 6,295 |
| 2016-05-05 | Open-market sale | 1,647 | $228.67 | 7,326 |
| 2015-05-19 | Grant / award (derivative) | 2,500 | $0.00 | 2,500 |
| 2014-06-10 | Grant / award (derivative) | 2,838 | $0.00 | 7,044 |
| 2014-04-28 | Grant / award (derivative) | 2,781 | $0.00 | 6,987 |
| 2014-04-01 | Grant / award (derivative) | 1,528 | — | 1,528 |
| 2014-04-01 | Grant / award (derivative) | 2,678 | — | 2,678 |
| 2014-04-01 | Grant / award | 6,404 | — | 6,404 |
| 2014-04-01 | Grant / award | 6,295 | — | 6,295 |
Source: SEC EDGAR Form 4 filings. For informational purposes only — not investment advice.